ChemDiv to provide Merck KGaA with discovery chemistry in multiyear agreement, extending ongoing collaboration
ChemDiv, Inc. announced that Merck KGaA has renewed and expanded on an agreement with ChemDiv as its preferred provider of discovery libraries of lead-like small molecules through 2009. The new agreement expands the collaboration that has been going on for the last three years, and roughly doubles the FTE effort at ChemDiv's Chemical Diversity Research Institute in Moscow.
Under the terms of the agreement, a steering committee with representatives from Merck KGaA and ChemDiv will determine projects to be produced by ChemDiv for early stage discovery at Merck. Promising hits will then be further optimized and placed into Merck's discovery pipeline. Financial terms were not disclosed.
Most read news
Other news from the department business & finance

Get the chemical industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.